Dalhousie University is a public research university in Nova Scotia, Canada, with three campuses in Halifax, a fourth in Bible Hill, and medical teaching facilities in Saint John, New Brunswick. Dalhousie offers more than 4,000 courses, and 180 degree programs in 12 undergraduate, graduate, and professional faculties.

During the past decade, Dalhousie University conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 5 clinical trials were completed, i.e. on average, 15.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 3 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dalhousie University" #1 sponsor was "Dalhousie University" with 5 trials, followed by "IWK Health Centre" with 4 trials sponsored, "Ottawa Heart Institute Research Corporation" with 4 trials sponsored, "University of British Columbia" with 4 trials sponsored and "Nova Scotia Health Authority" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dalhousie University" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 8 trials as a collaborator, "Dalhousie University" with 6 trials as a collaborator, "University of British Columbia" with 5 trials as a collaborator, "Nova Scotia Health Authority" with 4 trials as a collaborator and "Memorial University of Newfoundland" with 3 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Dalhousie University" are "Stroke" (5 trials), "Cardiovascular Diseases" (4 trials), "Brain Diseases" (3 trials), "Brain Infarction" (3 trials) and "Brain Ischemia" (3 trials). Many other conditions were trialed in "Dalhousie University" in a lesser frequency.

Most popular intervention types in "Dalhousie University" are "Drug" (20 trials), "Behavioral" (18 trials), "Other" (11 trials), "Procedure" (8 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Advanced Imaging" (2 trials), "Exercise Program" (2 trials), "Ribavirin" (2 trials) and "Standard Imaging" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dalhousie University" are 58 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dalhousie University". 2 are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Dalhousie University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Dalhousie University, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 27 trials that are defined as “Not Applicable".

Dalhousie University has several departments that took part in Clinical trials: "Queen Elizabeth II Health Sciences Centre; Oncology" - 17 trials, "Dalhousie MS Research Unit" - 6 trials, "Queen Elizabeth II Health Sciences Centre; Gastroenterology Research" - 5 trials, "QEII - HSC Department of Ophthalmology" - 4 trials, "Dalhousie University Faculty of Dentistry" - 3 trials, "NeuroCognitive Imaging Lab, Dalhousie University" - 2 trials, "QEII Health Sciences Centre (Dalhousie University)" - 6 trials, "Capital Health District Authority, Department of Medicine, Division of Nephrology" - 2 trials, "Dalhousie University Department of Psychiatry" - 2 trials